Slotervaartziekenhuis was a hospital in the Slotervaart neighbourhood of Amsterdam, the Netherlands. It went into administration in October 2018, and was closed within days.

During the past decade, Slotervaart Ziekenhuis conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Slotervaart Ziekenhuis" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials, followed by "ALK-Abelló A/S" with 1 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored, "Amsterdam UMC, location VUmc" with 1 trials sponsored and "Erasmus Medical Center" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Slotervaart Ziekenhuis" #1 collaborator was "Dutch Digestive Diseases Foundation" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Dirinco B.V." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Slotervaart Ziekenhuis" are "Colorectal Cancer" (2 trials), "Lung Cancer" (2 trials), "Lymphoma" (2 trials), "Acute Kidney Injury" (1 trials) and "Birch Pollen Allergy" (1 trials). Many other conditions were trialed in "Slotervaart Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Slotervaart Ziekenhuis" are "Drug" (7 trials), "Biological" (3 trials), "Other" (3 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "doxorubicin hydrochloride" (2 trials), "prednisone" (2 trials), "vincristine sulfate" (2 trials), "ALK tree AIT 0.5 DU" (1 trials) and "ALK tree AIT 1 DU" (1 trials). Other intervention names were less common.

The vast majority of trials in "Slotervaart Ziekenhuis" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Slotervaart Ziekenhuis". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Slotervaart Ziekenhuis, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Slotervaart Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".